Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hansfried Van Craenendonck"'
Autor:
Ilse Goris, Hansfried Van Craenendonck, Guy Daneels, Dieder Moechars, Ilse Lenaerts, J. Adriaan Bouwknecht, Thomas Steckler, Kim Cryns, Jos Prickaerts
Publikováno v:
Journal of Neuroscience, 26, 9022-9. Society for Neuroscience
Lithium is used as treatment for bipolar disorder with particular efficacy in the treatment of mania. Lithium inhibits glycogen synthase kinase 3 beta(GSK-3 beta) directly or indirectly via stimulation of the kinase Akt-1. We therefore investigated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61f52254e728bce2ce7962a0cebb27a
https://doi.org/10.1523/jneurosci.5216-05.2006
https://doi.org/10.1523/jneurosci.5216-05.2006
Autor:
Hansfried Van Craenendonck, Thomas Steckler, Kim Cryns, Ilse Goris, Dieder Moechars, Alon Shamir, Roel Straetemans, J. Shapiro, Galila Agam, Robert H. Belmaker, Gie Daneels
Publikováno v:
Neuropsychopharmacology. 32:881-891
Lithium is a potent mood-stabilizing medication in bipolar disorder. Despite 50 years of clinical use, the mechanism of action is unknown. Multiple effects have been attributed to lithium including the uncompetitive inhibition of inositol monophospha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66293272ad581eb85a8c443f2fe9d3ed
https://doi.org/10.1038/sj.npp.1301154
https://doi.org/10.1038/sj.npp.1301154
Publikováno v:
Journal of Biopharmaceutical Statistics. 15:225-239
The differential reinforcement of a low-rate 72-seconds schedule (DRL-72) is a standard behavioral test procedure for screening a potential antidepressant compound. The data analyzed in the article are binary outcomes from a crossover design for such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afe1f2756c8055413fdee92a30969571
https://doi.org/10.1081/bip-200049825
https://doi.org/10.1081/bip-200049825
Autor:
Nancy Aerts, Anne Simone Josephine Lesage, Ana M.M. Oliveira, Thomas Steckler, Hansfried Van Craenendonck, Anton Megens, Jos Prickaerts, Hilde Lavreysen
Publikováno v:
Psychopharmacology, 179, 198-206. Springer
Group I metabotropic glutamate receptor antagonists, which block both the mGlu1 and mGlu5 receptors, have been shown to have anxiolytic effects in the lick suppression test in rats. The anxiolytic potential of the selective mGlu1 antagonist 3,4-dihyd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::742f19bb1c89351ff798841da2ac57c6
https://doi.org/10.1007/s00213-004-2056-7
https://doi.org/10.1007/s00213-004-2056-7
Autor:
Xavier Langlois, Chistophe Van Dyck, Thomas Steckler, Ana F.M. Oliveira, Anne Simone Josephine Lesage, Hansfried Van Craenendonck, Ana M.A. Mateus, Jos Prickaerts
Publikováno v:
Behavioural Brain Research, 164, 52-60. Elsevier Science
Metabotropic glutamate receptors, including the mGlu1 receptor, have received considerable attention as potential targets for anxiolytic, antidepressant, antipsychotic and antinociceptive drugs. mGlu1 receptors have also been suggested to play a role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78360ff3c2061187c07c04b4e8b58ff6
https://pubmed.ncbi.nlm.nih.gov/16043241
https://pubmed.ncbi.nlm.nih.gov/16043241
Autor:
Ziv Shkedy, Veerle Vandersmissen, Geert Molenberghs, Hansfried Van Craenendonck, Nancy Aerts, Thomas Steckler, Luc Bijnens
Publikováno v:
Biometrical Journal; Jun2005, Vol. 47 Issue 3, p286-298, 13p